Expertise in
7
conditions

Christian U. Blank

Graf Adolf Str. 35-37, 
Duesseldorf, NW, DE 
Expertise in
7
conditions
Graf Adolf Str. 35-37, 
Duesseldorf, NW, DE 
OverviewLocationsClinical Research

Overview

Christian Blank practices in Duesseldorf, Germany. Mr. Blank is highly rated in 7 conditions, according to our data. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Metastatic Uveal Melanoma, Uveal Melanoma, and Nephrectomy.

His clinical research consists of co-authoring 310 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Graf Adolf Str. 35-37, Duesseldorf, NW 40210, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Vaccination Against cOvid In CancEr
Vaccination Against cOvid In CancEr
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Biological
Study Drug: Moderna mRNA-1273 COVID-19 Vaccine
Study Phase: Not Applicable
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Biological
Study Drug: Enapotamab vedotin 
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

310 Total Publications

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.
Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.
Journal: JAMA oncology
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Blank's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile